Differential transplacental binding of diazepam: Causes and implications

M. J. Ridd, K. F. Brown, R. L. Nation, C. B. Collier

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Diazepam plasma binding was determined in 17 matched pairs of maternal and foetal plasma, collected at delivery. Diazepam % free was higher (p<0.001) in maternal (mean 3.24%) than in either umbilical venous (mean 1.50%) or umbilical arterial (mean 1.24%) plasma. The data from in vitro dialysis studies were consistent with the reported higher diazepam concentrations in infants than in mothers at delivery. Plasma nonesterified fatty acids (NEFA) concentrations were higher (p<0.001) in maternal (x = 643 μM) than in matched umbilical venous plasma (x = 211 μM) and there was a significant correlation (p<0.01) between diazepam % free and corresponding plasma NEFA concentration for pooled data (r=0.871, n=34). Multiple and partial regression analysis indicates that transplacental differences in albumin, bilirubin and total protein concentrations made a minimal contribution to diazepam binding differences between mother and foetus and that approximately 76% of the variability in diazepam % free was accounted for by plasma NEFA concentration. The binding of diazepam to human serum albumin (HSA) was markedly perturbed by the presence of NEFA but not by bilirubin and there was no apparent cooperativity between bilirubin and NEFA on diazepam-HSA binding. Moreover, our findings provide further evidence that substantial differences in binding affinities exist between foetal and maternal plasma albumins.

Original languageEnglish
Pages (from-to)595-601
Number of pages7
JournalEuropean Journal of Clinical Pharmacology
Volume24
Issue number5
DOIs
Publication statusPublished - 1 Sep 1983

Keywords

  • diazepam
  • fatty acid binding
  • matched maternal and foetal plasma
  • plasma albumins
  • plasma bilirubin
  • plasma NEFA concentration

Cite this

Ridd, M. J. ; Brown, K. F. ; Nation, R. L. ; Collier, C. B. / Differential transplacental binding of diazepam : Causes and implications. In: European Journal of Clinical Pharmacology. 1983 ; Vol. 24, No. 5. pp. 595-601.
@article{4767b3699a564d81b0c9a9bc58a3ab06,
title = "Differential transplacental binding of diazepam: Causes and implications",
abstract = "Diazepam plasma binding was determined in 17 matched pairs of maternal and foetal plasma, collected at delivery. Diazepam {\%} free was higher (p<0.001) in maternal (mean 3.24{\%}) than in either umbilical venous (mean 1.50{\%}) or umbilical arterial (mean 1.24{\%}) plasma. The data from in vitro dialysis studies were consistent with the reported higher diazepam concentrations in infants than in mothers at delivery. Plasma nonesterified fatty acids (NEFA) concentrations were higher (p<0.001) in maternal (x = 643 μM) than in matched umbilical venous plasma (x = 211 μM) and there was a significant correlation (p<0.01) between diazepam {\%} free and corresponding plasma NEFA concentration for pooled data (r=0.871, n=34). Multiple and partial regression analysis indicates that transplacental differences in albumin, bilirubin and total protein concentrations made a minimal contribution to diazepam binding differences between mother and foetus and that approximately 76{\%} of the variability in diazepam {\%} free was accounted for by plasma NEFA concentration. The binding of diazepam to human serum albumin (HSA) was markedly perturbed by the presence of NEFA but not by bilirubin and there was no apparent cooperativity between bilirubin and NEFA on diazepam-HSA binding. Moreover, our findings provide further evidence that substantial differences in binding affinities exist between foetal and maternal plasma albumins.",
keywords = "diazepam, fatty acid binding, matched maternal and foetal plasma, plasma albumins, plasma bilirubin, plasma NEFA concentration",
author = "Ridd, {M. J.} and Brown, {K. F.} and Nation, {R. L.} and Collier, {C. B.}",
year = "1983",
month = "9",
day = "1",
doi = "10.1007/BF00542207",
language = "English",
volume = "24",
pages = "595--601",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer-Verlag London Ltd.",
number = "5",

}

Differential transplacental binding of diazepam : Causes and implications. / Ridd, M. J.; Brown, K. F.; Nation, R. L.; Collier, C. B.

In: European Journal of Clinical Pharmacology, Vol. 24, No. 5, 01.09.1983, p. 595-601.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Differential transplacental binding of diazepam

T2 - Causes and implications

AU - Ridd, M. J.

AU - Brown, K. F.

AU - Nation, R. L.

AU - Collier, C. B.

PY - 1983/9/1

Y1 - 1983/9/1

N2 - Diazepam plasma binding was determined in 17 matched pairs of maternal and foetal plasma, collected at delivery. Diazepam % free was higher (p<0.001) in maternal (mean 3.24%) than in either umbilical venous (mean 1.50%) or umbilical arterial (mean 1.24%) plasma. The data from in vitro dialysis studies were consistent with the reported higher diazepam concentrations in infants than in mothers at delivery. Plasma nonesterified fatty acids (NEFA) concentrations were higher (p<0.001) in maternal (x = 643 μM) than in matched umbilical venous plasma (x = 211 μM) and there was a significant correlation (p<0.01) between diazepam % free and corresponding plasma NEFA concentration for pooled data (r=0.871, n=34). Multiple and partial regression analysis indicates that transplacental differences in albumin, bilirubin and total protein concentrations made a minimal contribution to diazepam binding differences between mother and foetus and that approximately 76% of the variability in diazepam % free was accounted for by plasma NEFA concentration. The binding of diazepam to human serum albumin (HSA) was markedly perturbed by the presence of NEFA but not by bilirubin and there was no apparent cooperativity between bilirubin and NEFA on diazepam-HSA binding. Moreover, our findings provide further evidence that substantial differences in binding affinities exist between foetal and maternal plasma albumins.

AB - Diazepam plasma binding was determined in 17 matched pairs of maternal and foetal plasma, collected at delivery. Diazepam % free was higher (p<0.001) in maternal (mean 3.24%) than in either umbilical venous (mean 1.50%) or umbilical arterial (mean 1.24%) plasma. The data from in vitro dialysis studies were consistent with the reported higher diazepam concentrations in infants than in mothers at delivery. Plasma nonesterified fatty acids (NEFA) concentrations were higher (p<0.001) in maternal (x = 643 μM) than in matched umbilical venous plasma (x = 211 μM) and there was a significant correlation (p<0.01) between diazepam % free and corresponding plasma NEFA concentration for pooled data (r=0.871, n=34). Multiple and partial regression analysis indicates that transplacental differences in albumin, bilirubin and total protein concentrations made a minimal contribution to diazepam binding differences between mother and foetus and that approximately 76% of the variability in diazepam % free was accounted for by plasma NEFA concentration. The binding of diazepam to human serum albumin (HSA) was markedly perturbed by the presence of NEFA but not by bilirubin and there was no apparent cooperativity between bilirubin and NEFA on diazepam-HSA binding. Moreover, our findings provide further evidence that substantial differences in binding affinities exist between foetal and maternal plasma albumins.

KW - diazepam

KW - fatty acid binding

KW - matched maternal and foetal plasma

KW - plasma albumins

KW - plasma bilirubin

KW - plasma NEFA concentration

UR - http://www.scopus.com/inward/record.url?scp=0020638844&partnerID=8YFLogxK

U2 - 10.1007/BF00542207

DO - 10.1007/BF00542207

M3 - Article

VL - 24

SP - 595

EP - 601

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 5

ER -